Sm. Gardiner et al., The influence of antibodies to TNF-alpha and IL-1 beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats, BR J PHARM, 125(7), 1998, pp. 1543-1550
1 Male, Long Evans rats (350-450 g) were anaesthetized and had pulsed Doppl
er probes and intravascular catheters implanted to allow monitoring of regi
onal (renal, mesenteric and hindquarters) haemodynamics in the conscious st
ate. Our main objectives were to: assess the effects of administering human
recombinant tumour necrosis factor (TNF)-alpha and human recombinant inter
leukin-1 (IL-1)beta, alone and together; determine the influence of pretrea
tment with a mixture of antibodies to TNF-alpha and IL-1 beta on responses
to co-administration of the cytokines; ascertain if pretreatment with a mix
ture of the antibodies to TNF-alpha and IL-1 beta had any influence on the
responses to lipopolysaccharide (LPS).
2 TNF-alpha (10, 100 and 250 mu g kg(-1), in separate groups, n=3, 9 and 8,
respectively) caused tachycardia (maximum Delta, +101+/-9 beats min(-1)) a
nd modest hypotension (maximum Delta, - 10+/-2 mmHg), accompanied by variab
le changes in renal and mesenteric vascular conductance, but clear increase
s in hindquarters vascular conductance; only the latter were dose-related (
maximum Delta, + 6+/-6, +27+/-9, and + 61 +/- 12% at 10, 100 and 250 mu g k
g(-1), respectively).
3 IL-1 beta (1, 10, and 100 mu g kg(-1) in separate groups, n=8, 8 and 9, r
espectively) evoked changes similar to those of TNF-alpha (maximum a heart
rate, + 69 +/- 15 beats min(-1); maximum Delta mean blood pressure, - 14 +/
- 2 mmHg; maximum Delta hindquarters vascular conductance, + 49 +/- 17%), b
ut with no clear dose-dependency.
4 TNF-alpha (250 mu g kg(-1)) and IL-1 beta (10 mu g kg(-1)) together cause
d tachycardia (maximum Delta, +76 +/- 15 beats min(-1)) and hypotension (ma
ximum Delta, -24+/-2 mmHg) accompanied by increases in renal, mesenteric an
d hindquarters vascular conductances (+52+/-6%, +23+/-8%, and +52+/-11%, re
spectively). Thereafter, blood pressure recovered, in association with mark
ed reductions in mesenteric and hindquarters vascular conductances (maximum
Delta, -50+/-3% and -58+/-3% respectively). Although bolus injection of LP
S (3.5 mg kg(-1)) caused an initial hypotension (maximum Delta, -27+/-11 mm
Hg) similar to that seen with co-administration of the cytokines, it did no
t cause mesenteric or hindquarters vasodilatation, and there was only a slo
w onset renal vasodilatation. The recovery in blood pressure following LPS
was less than after the cytokines, and in the former condition there was no
mesenteric vasoconstriction. By 24 h after coadministration of TNF-alpha a
nd IL-1 beta or after bolus injection of LPS, the secondary reduction in bl
ood pressure was similar (-16+/-2 and -13+/-3 mmHg, respectively), but in t
he former group the tachycardia (+117+/-14 beats min(-1)) and increase in h
indquarters vascular conductance (+99+/-21%) were greater than after bolus
injection of LPS (+54+/-16 beats min(-1) and +43+/-9%, respectively).
5 Pretreatment with antibodies to TNF-alpha and IL-1 beta (300 mg kg(-1)) b
locked the initial hypotensive and mesenteric and hindquarters vasodilator
responses to co-administration of the cytokines subsequently. However, tach
ycardia and renal vasodilatation were still apparent. Premixing antibodies
and cytokines before administration prevented most of the effects of the la
tter, but tachycardia was still present at 24 h.
6 Pretreatment with antibodies to TNF-a and IL-IB before infusion of LPS (1
50 mu g kg(-1) h(-1) for 24 h) did not affect the initial fall in blood pre
ssure, but suppressed the hindquarters vasodilatation and caused a slight i
mprovement in the recovery of blood pressure. However, pretreatment with th
e antibodies had no effect on the subsequent cardiovascular sequelae of LPS
infusion.
7 The results indicate that although co-administration of TNF-alpha and IL-
1 beta can evoke cardiovascular responses which, in some respects, mimic th
ose of LPS, and although antibodies to the cytokines can suppress most of t
he cardiovascular effects of the cytokines, the antibodies have little infl
uence on the haemodynamic responses to LPS, possibly because, during infusi
on of LPS, the sites of production and local action of endogenous cytokines
, are not accessible to exogenous antibodies.